Translational Geroscience: Emphasizing function to achieve optimal longevity

Aging

Volumn 6, Issue 9, 2014, Pages 718-730

  Seals, Douglas R ^a   Melov, Simon ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Aging; Biomedical research; Healthspan; Lifespan; Physiology

Indexed keywords

ANIMAL; GERIATRICS; HUMAN; LONGEVITY; TRANSLATIONAL RESEARCH; TRENDS;

ANIMALS; GERIATRICS; HUMANS; LONGEVITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84907857762     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100694     Document Type: Article

References (57)

1. Seals DR and Melov S. Treat ageing. Preclinical studies. Track function in ageing animals. Nature. 2014; 511:406-407.
2. Olshansky SJ, Goldman DP, Zheng Y and Rowe JW. Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q. 2009; 87:842-862.
3. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med. 1980; 303:130-135.
4. Kirkland JL. Translating advances from the basic biology of aging into clinical application. Exper Gerontol. 2013; 48:1-5.
5. Rae MJ, Butler RN, Campisi J, de Grey AD, Finch CE, Gough M, Martin GM, Vijg J, Perrott KM and Logan BJ. The demographic and biomedical case for late-life interventions in aging. Sci Trans Med. 2010; 2:40cm21.
6. Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D and Olshansky SJ. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Affairs. 2013; 32:1698-1705.
7. Blagosklonny MV. How to save Medicare: the anti-aging remedy. Aging. 2012; 4:547-552.
8. Hadley EC, Lakatta EG, Morrison-Bogorad M, Warner HR and Hodes RJ. The future of aging therapies. Cell. 2005; 120:557-567.
9. Butler RN, Miller RA, Perry D, Carnes BA, Williams TF, Cassel C, Brody J, Bernard MA, Partridge L, Kirkwood T, Martin GM and Olshansky SJ. New model of health promotion and disease prevention for the 21st century. Brit Med J. 2008; 337:7662.
10. Olshansky SJ, Carnes BA and Cassel C. In search of Methuselah - estimating the upper limits to human longevity. Science. 1990; 250:634-640.
11. Johnson TE. 25 years after age-1: genes, interventions and the revolution in aging research. Exper Gerontol. 2013; 48:640-643.
12. Vijg J, Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008; 454(7208):1065-1071.
13. Kenyon CJ. The genetics of ageing. Nature. 2010; 464:504-512.
14. Curtis C, Landis GN, Folk D, Wehr NB, Hoe N, Waskar M, Abdueva D, Skvortsov D, Ford D, Luu A, Badrinath A, Levine RL, Bradley TJ, et al. Transcriptional profiling of MnSOD-mediated lifespan extension in drosophila reveals a species-general network of aging and metabolic genes. Genome Biol. 2007; 8.
15. Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, Zykovich A, Mooney SD, Strong R, Rosen CJ, Kapahi P, Nelson MD, Kennedy BK, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013; 12:851-862.
16. Zhang YQ, Bokov A, Gelfond J, Soto V, Ikeno Y, Hubbard G, Diaz V, Sloane L, Maslin K, Treaster S, Rendon S, van Remmen H, Ward W, et al. Rapamycin extends life and health in C57BL/6 mice. J Gerontol a-Biol. 2014; 69:119-130.
17. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, Strong R, Richardson A and Oddo S. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1 ss and enhancing NMDA signaling. Aging Cell. 2012; 11:326-335.
18. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA and Miller RA. Rapamycin slows aging in mice. Aging Cell. 2012; 11:675-682.
19. Lipton RB, Hirsch J, Katz MJ, Wang CL, Sanders AE, Verghese J, Barzilai N and Derby CA. Exceptional parental longevity associated with lower risk of Alzheimer's Disease and memory decline. J Am Geriatr Soc. 2010; 58:1043-1049.
20. Willcox BJ, Willcox DC and Ferrucci L. Secrets of healthy aging and longevity from exceptional survivors around the globe: lessons fom octogenarians to supercentenarians. J Gerontol a-Biol. 2008; 63:1181-1185.
21. Fraser GE and Shavlik DJ. Ten years of life - Is it a matter of choice? Arch Intern Med. 2001; 161:1645-1652.
22. Beeson WL, Mills PK, Phillips RL, Andress M and Fraser GE. Chronic disease among seventh-day adventists, a low-risk group - rationale, methodology, and description of the population. Cancer. 1989; 64:570-581.
23. Holloszy J, Smith E, Vining M and Adams S. Effect of voluntary exercise on longevity in rats. J Appl Physiol. 1985;59:826-831.
24. Chakravarty EF, Hubert HB, Lingala VB and Fries JF. Reduced disability and mortality among aging runners - A 21-year longitudinal study. Arch Intern Med. 2008; 168:1638-1646.
25. Samorajski T, Delaney C, Durham L, Ordy JM, Johnson JA and Dunlap WP. Effect of exercise on longevity, body-weight, locomotor performance, and passive-avoidance memory of C57bl/6j mice. Neurobiol Aging. 1985; 6:17-24.
26. Kirkland JL and Peterson C. Healthspan, translation, and new outcomes for animal studies of aging. J Gerontol a-Biol. 2009;64:209-212.
27. Seals DR. Translational physiology: from molecules to public health. J Physiol. 2013; 591:3457-3469.
28. Woolf SH. The meaning of translational research and why it matters. J Am Med Assoc. 2008; 299(2):211-213.
29. Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Cell Cycle. 2010;9:4788-4794.
30. Fried LP, Xue QL, Cappola AR, Ferrucci L, Chaves P, Varadhan R, Guralnik JM, Leng SX, Semba RD, Walston JD, Blaum CS and Bandeen-Roche K. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol a-Biol. 2009;64:1049-1057.
31. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D and Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010; 121:505-511.
32. Facchini FS, Hua N, Abbasi F and Raven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab. 2001; 86:3574-3578.
33. Yeboah J, Crouse JR, Hsu FC, Burke GL and Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults - The Cardiovascular Health Study. Circulation. 2007; 115:2390-2397.
34. Carter CS, Sonntag WE, Onder G and Pahor M. Physical performance and longevity in aged rats. J Gerontol a-Biol. 2002;57:B193-197.
35. Rantanen T, Masaki K, Qimei H, Ross GW, Willcox BJ and White L. Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decent cohort. Age. 2012; 34:563-570.
36. Buchman AS, Wilson RS, Boyle PA, Bienias JL and Bennett DA. Change in motor function and risk of mortality in older persons. J Am Geriatr Soc. 2007; 55:11-19.
37. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, et al. Gait speed and survival in older adults. J Am Med Assoc. 2011; 305:50-58.
38. Joyner MJ and Pedersen BK. Ten questions about systems biology. J Physiol. 2011; 589:1017-1030.
39. LaRocca TJ, Henson GD, Thorburn A, Sindler AL, Pierce GL and Seals DR. Translational evidence that impaired autophagy contributes to arterial ageing. J Physiol. 2012; 590:3305-3316.
40. Alexander GE, Ryan L, Bowers D, Foster TC, Bizon JL, Geldmacher DS and Glisky EL. Characterizing cognitive aging in humans with links to animal models. Front Aging Neurosci. 2012;4:21.
41. Justice JN, Carter CS, Beck HJ, Gioscia-Ryan RA, McQueen MB, Enoka RM and Seals DR. Battery of behavioral tests in mice that models age-associated changes in human motor function. Age. 2014; 36:583-595.
42. Seals DR, Kaplon RE, Gioscia-Ryan RA and LaRocca TJ. Translational strategies for preserving vascular endothelial function with aging. Physiology(Bethesda). 2014; 29:250-264.
43. Liu H, Graber TG, Ferguson-Stegall L and Thompson LV. Clinically relevant frailty index for mice. J Gerontol a-Biol. 2013.
44. Graber TG, Ferguson-Stegall L, Kim JH and Thompson LV. C57BL/6 neuromuscular healthspan scoring system. J Gerontol a-Biol. 2013; 68:1326-1336.
45. Walston J, Fedarko N, Yang H, Leng S, Beamer B, Espinoza S, Lipton A, Zheng H and Becker K. The physical and biological characterization of a frail mouse model. J Gerontol a-Biol. 2008;63:391-398.
46. Carter CS, Marzetti E, Leeuwenburgh C, Manini T, Foster TC, Groban L, Scarpace PJ, Morgan D. Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopenia. J Gerontol a-Biol. 2012; 67:17-27.
47. Gershon RC, Wagster MV, Hendrie HC, Fox NA, Cook KF and Nowinski CJ. NIH Toolbox for assessment of neurological and behavioral function. Neurology. 2013; 80:S2-S6.
48. Working-Group. Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol a-Biol. 2009; 64A:487-491.
49. Vellas B, Pahor M, Manini T, Rooks D, Guralnik JM, Morley J, Studenski S, Evans W, Asbrand C, Fariello R, Pereira S, Rolland Y, Van Kan GA, et al. Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. J Nutr Health Aging. 2013; 17:612-618.
50. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J Gerontol a-Biol. 2014;69:547-558.
51. Ferrucci L, de Cabo R, Knuth ND and Studenski S. Of Greek heroes, wiggling worms, mighty mice, and old body builders. J Gerontol a-Biol. 2012; 67:13-16.
52. Johnson TE. Subfield history: caenorhabditis elegans as a system for analysis of the genetics of aging science's SAGE KE. Sci Aging Know Environ. 2002; re4.
53. Donato AJ, Walker AE, Magerko KA, Bramwell RC, Black AD, Henson GD, Lawson BR, Lesniewski LA and Seals DR. Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice. Aging Cell. 2013; 12:772-783.
54. Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005; 126:913-922.
55. Skalicky M, BubnaLittitz H and Viidik A. Influence of physical exercise on aging rats .1. Life-long exercise preserves patterns of spontaneous activity. Mech Ageing Dev. 1996; 87:127-139.
56. Navarro A, Gomez C, Lopez-Cepero JM and Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol-Reg I. 2004; 286:R505-R511.
57. Melov S, Tarnopolsky MA, Beckman K, Felkey K and Hubbard A. Resistance exercise reverses aging in human skeletal muscle. PloS One. 2007; 2.